Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Elchonon M. Berkowitz"'
Autor:
Zhengyu Xue, Aparna Raychaudhuri, David Gardiner, David Tenero, Yanwen Qian, Elchonon M. Berkowitz, Courtney Tiffany, Nicholas Farinola
Publikováno v:
Clinical pharmacology in drug development. 8(6)
This was a first-time-in-human randomized, double-blind, single-center, placebo-controlled dose-escalation study to determine the safety, tolerability, and pharmacokinetic (PK) profiles of GSK3342830 after single and repeat intravenous doses in healt
Autor:
Sanjeet Dadwal, Elchonon M. Berkowitz, Francisco M. Marty, Thomas C. Heineman, Francis K. Buadi, Genovefa A. Papanicolaou, Thomas C. Shea, Mohamed El Idrissi, Jo Anne H. Young, Charalambos Andreadis, Edward A. Stadtmauer, Keith M. Sullivan, Sherif B. Mossad
Publikováno v:
Blood. 124:2921-2929
Recombinant herpes zoster (HZ) vaccines may be an alternative to the live-attenuated HZ vaccine for immunocompromised individuals. This was a phase 1/2, randomized, observer-blind, placebo-controlled study in adults with multiple myeloma, non-Hodgkin
Autor:
Stefan Schneider, Jacob Lalezari, Dirk Schürmann, Trevor Hawkins, Stephen Kegg, Stefan Esser, Graeme Moyle, Matthias Stoll, Lidia Oostvogels, Edwin DeJesus, Thomas C. Heineman, Hans-Jürgen Stellbrink, Elchonon M. Berkowitz, Mohamed El Idrissi, Chloe Orkin, Norbert H. Brockmeyer
Publikováno v:
The Journal of Infectious Diseases
Background. Human immunodeficiency virus (HIV)–infected individuals are at increased risk of herpes zoster (HZ), even in the antiretroviral therapy (ART) era. Because concerns exist about the use of live-attenuated vaccines in immunocompromised ind
Autor:
Monique Twynholm, Jack B. Anon, Michael D. Poole, Brian Wynne, Elchonon M. Berkowitz, Berrylin J. Ferguson
Publikováno v:
Ear, Nose & Throat Journal. 85:500-508
We evaluated the efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2,000/125 mg) twice daily for the treatment of acute bacterial rhinosinusitis (ABRS) caused by Streptococcus pneumoniae, particularly penicillin-r
Publikováno v:
American Journal of Otolaryngology. 27:248-254
Purpose Acute bacterial rhinosinusitis (ABRS) is a common and uncomfortable condition, frequently caused by Streptococcus pneumoniae or Haemophilus influenzae. Antibacterial resistance among these and other common respiratory pathogens is now widespr
Autor:
Michael R. Jacobs, Monique Twynholm, Elchonon M. Berkowitz, Javier Garau, Brian Wynne, Thomas M. File
Publikováno v:
International Journal of Antimicrobial Agents. 25:110-119
Community-acquired pneumonia (CAP) is a common respiratory illness, frequently caused by Streptococcus pneumoniae. The prevalence of S. pneumoniae resistance to common antimicrobials has increased over recent years. A new pharmacokinetically enhanced
Autor:
M. Mcteague, F. F. V. Rose, H. Jousimies-Somer, Hannah M. Wexler, C. Jakielaszek, Elchonon M. Berkowitz, Sydney M. Finegold, M. J. Flynn, Brian Wynne
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 35(4)
An open-label, multicenter study was performed to assess bacteriologic findings associated with chronic bacterial maxillary sinusitis in adults. Seventy aerobic (52.2%) and 64 anaerobic (47.8%) pathogens were recovered from clinically evaluable patie
Autor:
Thomas C. Shea, Elchonon M. Berkowitz, Jo Anne H. Young, Mohamed El Idrissi, Keith M. Sullivan, Mindy G. Schuster, Charalambos Andreadis, Sherif B. Mossad, Edward A. Stadtmauer, Thomas C. Heineman, Francis K. Buadi, Genovefa A. Papanicoleau, Sanjeet Dadwal, Francisco M. Marty
Publikováno v:
Biology of Blood and Marrow Transplantation. (2):S168-S169